Latest News

Learn about a new concept for restoring sight to damaged eyes, how researchers are turning a patients’ own cells into retinal ganglion cells, a discussion regarding the medical vs. surgical treatment of glaucoma, and more in the summer edition of our glaucoma newsletter.

Research funded by BrightFocus Foundation could lead to new drugs and therapies that prevent vision loss in glaucoma more effectively than pressure-lowering treatments alone.

Learn about research exploring the mechanisms of eye pressure regulation, which could lead to improved glaucoma treatments, five tips for using glaucoma eye drops, information about childhood glaucoma, and more in the winter edition of the winter edition of our glaucoma newsletter.

Explore the mystery of normal-tension glaucoma, a medication that may reduce the risk of open-angle glaucoma, learn about 15 new glaucoma research grants awarded by BrightFocus Foundation, and more in the fall edition of our glaucoma newsletter.

Download the summer 2015 issue of our glaucoma newsletter to learn about how a healthy diet leads to healthy eyes, how to make your computer vision-friendly, and much more.

Thanks to the mammoth worldwide effort to collect genetic information on glaucoma patients, there’s been a major breakthrough with the discovery of several new gene variants associated with severe glaucoma. The latest discoveries double the number of genes found through earlier studies and lend hope that genetic screening can be used to identify and direct treatment for people at highest risk of losing their sight.

Scientists have for the first time identified molecules with the potential to block the accumulation of a toxic eye protein that can lead to early onset of glaucoma. Researchers have implicated a mutant form of a protein called myocilin as a possible root cause of this increased eye pressure.

It’s just been announced that Jeffrey Goldberg, MD, PhD, of the University of California, San Diego (UCSD) will share a $1 million grant from the U.S. Department of Defense (DoD) for a two-year project to develop whole-eye transplantation techniques in an animal model.

Optical coherence tomography (OCT), magnetic resonance imaging (MRI), and other techniques are improving our ability to look deep inside the eye. Thanks to National Glaucoma Research funding, BrightFocus researchers are among those who have advanced new imaging methods, taking them from experimental stages to their new threshold, where they wait to become standard as clinical tools.